Therapeutics for Eliminating Hepatitis B Virus cccDNA (R21/R33)
| קרן | National Institute of Allergy and Infectious Diseases/NIH |
|---|---|
| מדינה | U.S.A. |
| סוג | Research Grants |
| תאריך אחרון | 14/02/2023 |
| פקולטה | Life Sciences, Medicine |
| תיאור | The purpose of this grant is to invite applications aimed at discovery of new antivirals that result in the transcriptional suppression and elimination of HBV cccDNA from infected cells.
Funding: R21 $275,000 total; R33 $300,000 per year Duration: R21 2 years; R33 3 years
Research Authority due date: 4.1.23 LOI (encouraged) due date: 14.1.23 Full proposal due date: 14.2.23
|
| קבצים מצורפים | |
| קישור | לאתר |
| עדכון אחרון | עדכון אחרון: 19/10/2022 |
